文献速递临床试验与 GCP

针对日本临床环境中社交焦虑障碍的翻译与文化适配网络认知治疗:随机对照试验研究方案

Translated and culturally adapted internet-delivered cognitive therapy for social anxiety disorder in Japanese clinical settings: study protocol for a randomised controlled trial.
PubMed 文献 · Trials · 2024-07-19

该研究为双臂平行组优效性随机对照试验,计划纳入60名社交焦虑障碍日本来访者,按1:1随机分配至日语网络认知治疗联合常规治疗组或单纯常规治疗组。主要结局为Liebowitz社交焦虑量表自评,评估时间点为基线(第0周)、治疗中期(第8周)和治疗后(第15周),联合治疗组另设3个月随访(第27周)。

要点

  • 日语版网络认知治疗联合常规治疗对比单纯常规治疗,主要结局为Liebowitz社交焦虑量表自评。
  • 计划纳入60名社交焦虑障碍日本来访者,按1:1随机分组,主要分析基于意向性治疗原则。
  • 评估时间点为第0、8、15周,联合治疗组另设第27周随访。

核心结论

  • 该试验旨在评估日语版网络认知治疗联合常规治疗对社交焦虑障碍的临床疗效,原文指出在不同文化背景下考察翻译与文化适配后的网络认知治疗疗效是评估网络干预全球可及性的重要一步。

研究设计与样本

  • 研究为双臂平行组优效性随机对照试验,计划招募60名社交焦虑障碍日本来访者,按1:1随机分配至日语网络认知治疗联合常规治疗组或单纯常规治疗组。
  • 主要分析基于意向性治疗原则,采用线性混合效应模型比较组间主要和次要结局指标,并进行中介分析。
  • 评估时间点为基线(第0周)、治疗中期(第8周)和治疗后(第15周),联合治疗组另设3个月随访(第27周)。

主要发现

  • 原文为研究方案,未报告试验结果。

关键数值与推荐

  • 主要结局指标为Liebowitz社交焦虑量表自评。
  • 次要结局包括其他社交焦虑症状及过程测量、一般情绪与功能以及治疗反应,并评估治疗可接受性及收集参与者反馈。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cognitive therapy for social anxiety disorder (CT-SAD) has extensive empirical support and is recommended in several national guidelines. However, ensuring access to evidence-based psychological therapies such as CT-SAD remains a global challenge. An internet-delivered version of this treatment protocol (iCT-SAD) has recently been developed in the UK as a way to overcome this challenge, demonstrating comparable outcomes to face-to-face CT-SAD whilst requiring less therapist time per client. Initial findings also suggest its cross-cultural transferability, but the previous studies in other cultural settings used the English language programme and only included English-fluent participants as a second language. It is not yet known what outcomes can be achieved once the programme has been translated and adapted for a different cultural context. Therefore, this trial aims to evaluate the clinical efficacy of Japanese iCT-SAD when combined with treatment as usual (TAU) in clients with SAD. METHODS: This two-arm, parallel-group, superiority randomised controlled trial will recruit 60 Japanese participants with SAD, randomly assigning them to either Japanese iCT-SAD + TAU or TAU alone at a ratio of 1:1. The primary outcome measure is the self-report Liebowitz Social Anxiety Scale, and secondary.outcomes include other measures of social anxiety symptoms and processes, general mood and functioning, and response to treatment. We will also assess treatment acceptability and gather participant feedback. Assessments will take place at baseline (week 0), mid-treatment (week 8), and post-treatment (week 15), with a further 3-month follow-up (week 27) for the iCT-SAD + TAU arm. The primary analyses will be conducted on an intent-to-treat basis, comparing the primary and secondary outcome measures between groups using linear mixed-effect models, along with additional mediation analysis. DISCUSSION: Investigating the efficacy of translated and culturally adapted iCT-SAD in different cultural contexts is an important step in evaluating the global reach of internet interventions. This trial will provide valuable insights into the effects of iCT-SAD combined with usual care, and how this treatment could be delivered in routine clinical settings in Japan. TRIAL REGISTRATION: International Standard Randomized Controlled Trials (ISRCTN), ISRCTN82859645, registered on January 19, 2024. UMIN Clinical Trials Registry (UMIN-CTR), UMIN000052702, registered on November 6, 2023.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Yoshinaga N, Thew GR, Hayashi Y, et al. Translated and culturally adapted internet-delivered cognitive therapy for social anxiety disorder in Japanese clinical settings: study protocol for a randomised controlled trial. Trials. 2024. PMID: 39030620. doi:10.1186/s13063-024-08303-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。